News
The 2018 accelerated approval of Vitrakvi was converted to full approval based on results from three trials in adult and pediatric patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback